Literature DB >> 2219262

Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions.

D B Brubaker1.   

Abstract

Febrile nonhemolytic transfusion reactions (FNHTRs) are associated with white cell (WBC) antibodies. The purposes of this study were to determine the frequency of WBC antibodies, to associate the severity of reactions with antibody specificity, and to distinguish FNHTRs from infection and postoperative fever. By using the granulocyte indirect immunofluorescence test in conjunction with lymphocytotoxicity testing, it was found that 70 percent of FNHTRs in 24 patients involved WBC antibodies. The remaining 30 percent of apparent FNHTRs were associated with infections and postoperative fever. Granulocyte-specific antibodies were as prevalent as HLA antibodies and were associated with the severest reactions. Because FNHTRs occur with granulocyte-specific antibodies, HLA antibodies, and possible monocyte-specific antibodies (untested in this and other studies), these reactions could be grouped together as WBC-associated reactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2219262     DOI: 10.1046/j.1537-2995.1990.30891020335.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Efficacy of leucocyte filters during transfusions in preventing the development of anti-HLA antibodies.

Authors:  S Kurul; H Ozkan; O Anal; N Akkoç; G Irken
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

2.  Clinical response and transfusion reactions of sheep subjected to single homologous blood transfusion.

Authors:  Rejane Santos Sousa; Antonio Humberto Hamad Minervino; Carolina Akiko Sato Cabral Araújo; Frederico Augusto Mazzocca Lopes Rodrigues; Francisco Leonardo Costa Oliveira; Clara Satsuki Mori; Janaina Larissa Rodrigues Zaminhan; Thiago Rocha Moreira; Isadora Karolina Freitas Sousa; Enrico Lippi Ortolani; Raimundo Alves Barrêto
Journal:  ScientificWorldJournal       Date:  2014-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.